- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
Psoriasis treatment advances
There has been a boon in advances for the treatment of psoriasis, spanning an arsenal of new biologic therapies. As a group, biologics are already the most prescribed systemic medications for the treatment of psoriasis, according to Mark Lebwohl, M.D., Mount Sinai School of Medicine, New York City, who discussed many on the market.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Bridging the Gaps in Lichen Planus Treatment: Emerging Therapies and Clinical Realities
Adam Friedman, MD, FAAD: Spotlighting Disparities in Lichen Planus Screening and Treatment
Road to RAD: Taking Itch Into Consideration
SDNP President Amanda Caldwell, MSN, APRN-C, on Empowering NPs Through Enhanced Support and Education
Derm Dispatch: Melanoma Doesn’t Wait—Neither Should You
Road to RAD: Lebrikizumab for AD
From Patient to President: Amanda Caldwell, MSN, APRN-C, And Her Journey with SDNP
Road to RAD: Nemolizumab for AD
Revolutionizing Acne Treatments and Skin Care with Cold Plasma Technology
Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD
Related Content
